Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Brain Scientific's Revenue for the
three
months ended in Dec. 2022 was $0.01 Mil. Brain Scientific's average Accounts Receivable for the
three
months ended in Dec. 2022 was $0.00 Mil.
Hence, Brain Scientific's Receivables Turnover for the
three
months ended in Dec. 2022 was 1.43.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Brain Scientific Receivables Turnover Related Terms
Brain Scientific Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Brain Scientific's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BRSF vs MOTS, BRSF, PBIO: Receivables Turnover Comparison
For the Medical Devices subindustry, Brain Scientific's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Brain Scientific Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Brain Scientific's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Brain Scientific's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Brain Scientific (BRSF) has a Receivables Turnover of 1.43 as of Dec. 2022. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Brain Scientific and its competitors.
Is Brain Scientific's Receivables Turnover too high?
Brain Scientific's current Receivables Turnover is 1.43. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. Brain Scientific's value of 1.43 is 74% below this industry median. Overall, Brain Scientific has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Brain Scientific's Receivables Turnover compare to MOTS and BRSF?
Brain Scientific's Receivables Turnover of 1.43 can be compared against companies in the Medical Devices & Instruments industry. The industry median Receivables Turnover is 5.51. Brain Scientific's value of 1.43 is 74% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Brain Scientific's current Receivables Turnover of 1.43 is 74% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Brain Scientific and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Brain Scientific's current Receivables Turnover is 1.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Brain Scientific stock overvalued right now?
Brain Scientific (BRSF) has a current Receivables Turnover of 1.43. The current Receivables Turnover is 1.43 and 74% below the Medical Devices & Instruments industry median of 5.51. Brain Scientific's overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Brain Scientific (BRSF), the current Receivables Turnover is 1.43 as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Brain Scientific Inc is a medical technology company with two product lines: neurology products are medical devices and software products designed for the neurology market. and motion products are small piezoelectric motors that are designed for and expected to have valuable and beneficial uses as motors within medical devices and devices outside of the medical technology industry.
10GF Score
Get the complete analysis for BRSF
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BRSF has been successfully added to your 
